- Home
- FTV vs JAZZ Comparison
FTV vs JAZZ Comparison
Compare FTV & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FTV | JAZZ |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | United States | Ireland |
| Employees | 18000 | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.1B | 15.6B |
| IPO Year | 2015 | 2007 |
Fundamental Metrics
Financial Performance| Metric | FTV | JAZZ |
|---|---|---|
| Price | $61.70 | $247.83 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 14 |
| Target Price | $59.18 | ★ $217.57 |
| AVG Volume (30 Days) | ★ 2.4M | 789.8K |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.39% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.44 | ★ 4.43 |
| Revenue | ★ $6,452,700,000.00 | $1,618,693,000.00 |
| Revenue This Year | $4.85 | $6.22 |
| Revenue Next Year | $3.74 | $7.68 |
| P/E Ratio | $141.80 | ★ $54.80 |
| Revenue Growth | ★ 12.10 | N/A |
| 52 Week Low | $46.34 | $105.00 |
| 52 Week High | $64.34 | $250.49 |
Technical Indicators
Market Signals| Indicator | FTV | JAZZ |
|---|---|---|
| Relative Strength Index (RSI) | 51.85 | 62.61 |
| Support Level | $57.95 | $222.49 |
| Resistance Level | $63.24 | $250.49 |
| Average True Range (ATR) | 1.40 | 7.32 |
| MACD | -0.08 | -0.00 |
| Stochastic Oscillator | 37.72 | 87.70 |
Price Performance
Historical ComparisonAbout FTV Fortive Corporation
Fortive Corp is a diversified industrial technology firm offering essential technologies, software, and services globally across several industries, such as manufacturing, utilities, medical, electronics, etc. It has two reportable segments: Intelligent Operating Solutions and Advanced Healthcare Solutions. Maximum revenue is generated from the Intelligent Operating Solutions segment, which offers professional instruments used in applications like maintenance, repair, measurement, and condition monitoring, connected worker safety, compliance solutions, etc. The products and services in this segment are marketed under various brands, including Fluke, Servicechannel, Gordian, Accruent, Industrial Scientific, and Intelex. Geographically, the firm generates maximum revenue from North America.
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.